US Patent Issued to SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, ENCELL on Dec. 9 for "Pharmaceutical composition, for preventing or treating Charcot-Marie-Tooth disorder, comprising mesenchymal stem cells or insulin secreted by mesenchymal stem cells" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,233, issued on Dec. 9, was assigned to SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, South Korea) and ENCELL Co. LTD (Seoul, South Korea).

"Pharmaceutical composition, for preventing or treating Charcot-Marie-Tooth disorder, comprising mesenchymal stem cells or insulin secreted by mesenchymal stem cells" was invented by Jong Wook Chang (Seoul, South Korea), Hong Bae Jeon (Seoul, South Korea), Sang Eon Park (Gyeonggi-do, South Korea) and Shin Ji Oh (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition, for preventing or treating Charcot-Marie-Tooth disorder, comprising mesench...